Initiated registrational Phase 2b SAFEGUARD trial of SAB-142 in new-onset, Stage 3 autoimmune T1D patientsMultiple SAFEGUARD ...
We envision a future where Serve Robotics' fleet reaches 1,000,000 robots deployed across cities globally. They will travel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback